nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCC4—Methotrexate—ankylosing spondylitis	0.15	0.305	CbGbCtD
Dipyridamole—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0957	0.194	CbGbCtD
Dipyridamole—ABCB1—Betamethasone—ankylosing spondylitis	0.0622	0.126	CbGbCtD
Dipyridamole—ABCB1—Prednisolone—ankylosing spondylitis	0.0614	0.125	CbGbCtD
Dipyridamole—ABCB1—Prednisone—ankylosing spondylitis	0.058	0.118	CbGbCtD
Dipyridamole—ABCB1—Dexamethasone—ankylosing spondylitis	0.0362	0.0735	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—ankylosing spondylitis	0.0291	0.0591	CbGbCtD
Dipyridamole—PDE8B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00204	0.0312	CbGpPWpGaD
Dipyridamole—PDE8A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00204	0.0312	CbGpPWpGaD
Dipyridamole—PDE2A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00199	0.0304	CbGpPWpGaD
Dipyridamole—PDE7B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00182	0.0278	CbGpPWpGaD
Dipyridamole—PDE11A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00169	0.0258	CbGpPWpGaD
Dipyridamole—PDE7A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00169	0.0258	CbGpPWpGaD
Dipyridamole—ADA—Validated transcriptional targets of deltaNp63 isoforms—IL1A—ankylosing spondylitis	0.00168	0.0257	CbGpPWpGaD
Dipyridamole—PDE10A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00151	0.023	CbGpPWpGaD
Dipyridamole—PDE3B—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.00136	0.0208	CbGpPWpGaD
Dipyridamole—PDE1C—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00127	0.0194	CbGpPWpGaD
Dipyridamole—ABCC5—Defective B3GAT3 causes JDSSDHD—B3GNT2—ankylosing spondylitis	0.00126	0.0192	CbGpPWpGaD
Dipyridamole—Syncope—Methylprednisolone—ankylosing spondylitis	0.0012	0.0027	CcSEcCtD
Dipyridamole—Oedema—Prednisolone—ankylosing spondylitis	0.00119	0.00268	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00119	0.00268	CcSEcCtD
Dipyridamole—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00117	0.00266	CcSEcCtD
Dipyridamole—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00117	0.00265	CcSEcCtD
Dipyridamole—Shock—Prednisolone—ankylosing spondylitis	0.00117	0.00264	CcSEcCtD
Dipyridamole—Cough—Triamcinolone—ankylosing spondylitis	0.00117	0.00264	CcSEcCtD
Dipyridamole—Convulsion—Triamcinolone—ankylosing spondylitis	0.00116	0.00262	CcSEcCtD
Dipyridamole—Tachycardia—Prednisolone—ankylosing spondylitis	0.00116	0.00262	CcSEcCtD
Dipyridamole—SLC29A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00116	0.0177	CbGpPWpGaD
Dipyridamole—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00115	0.00261	CcSEcCtD
Dipyridamole—Hypertension—Triamcinolone—ankylosing spondylitis	0.00115	0.00261	CcSEcCtD
Dipyridamole—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00115	0.0026	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00115	0.00259	CcSEcCtD
Dipyridamole—Myalgia—Triamcinolone—ankylosing spondylitis	0.00114	0.00257	CcSEcCtD
Dipyridamole—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00113	0.00257	CcSEcCtD
Dipyridamole—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00113	0.00257	CcSEcCtD
Dipyridamole—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00113	0.00256	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00113	0.00255	CcSEcCtD
Dipyridamole—Flushing—Prednisone—ankylosing spondylitis	0.00113	0.00255	CcSEcCtD
Dipyridamole—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00112	0.00254	CcSEcCtD
Dipyridamole—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00112	0.00254	CcSEcCtD
Dipyridamole—Discomfort—Triamcinolone—ankylosing spondylitis	0.00112	0.00254	CcSEcCtD
Dipyridamole—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00112	0.00254	CcSEcCtD
Dipyridamole—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00111	0.00252	CcSEcCtD
Dipyridamole—Angioedema—Betamethasone—ankylosing spondylitis	0.00111	0.00251	CcSEcCtD
Dipyridamole—Angioedema—Dexamethasone—ankylosing spondylitis	0.00111	0.00251	CcSEcCtD
Dipyridamole—Angiopathy—Prednisone—ankylosing spondylitis	0.0011	0.00249	CcSEcCtD
Dipyridamole—Immune system disorder—Prednisone—ankylosing spondylitis	0.0011	0.00248	CcSEcCtD
Dipyridamole—Malaise—Dexamethasone—ankylosing spondylitis	0.00109	0.00247	CcSEcCtD
Dipyridamole—Malaise—Betamethasone—ankylosing spondylitis	0.00109	0.00247	CcSEcCtD
Dipyridamole—Oedema—Triamcinolone—ankylosing spondylitis	0.00109	0.00247	CcSEcCtD
Dipyridamole—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00109	0.00247	CcSEcCtD
Dipyridamole—Vertigo—Betamethasone—ankylosing spondylitis	0.00109	0.00246	CcSEcCtD
Dipyridamole—Vertigo—Dexamethasone—ankylosing spondylitis	0.00109	0.00246	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00109	0.00246	CcSEcCtD
Dipyridamole—Syncope—Betamethasone—ankylosing spondylitis	0.00109	0.00246	CcSEcCtD
Dipyridamole—Syncope—Dexamethasone—ankylosing spondylitis	0.00109	0.00246	CcSEcCtD
Dipyridamole—Arrhythmia—Prednisone—ankylosing spondylitis	0.00108	0.00245	CcSEcCtD
Dipyridamole—Shock—Triamcinolone—ankylosing spondylitis	0.00107	0.00243	CcSEcCtD
Dipyridamole—Alopecia—Prednisone—ankylosing spondylitis	0.00107	0.00242	CcSEcCtD
Dipyridamole—Shock—Methylprednisolone—ankylosing spondylitis	0.00107	0.00242	CcSEcCtD
Dipyridamole—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00107	0.00241	CcSEcCtD
Dipyridamole—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00107	0.00241	CcSEcCtD
Dipyridamole—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00107	0.00241	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00106	0.00241	CcSEcCtD
Dipyridamole—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00106	0.00241	CcSEcCtD
Dipyridamole—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00106	0.0024	CcSEcCtD
Dipyridamole—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00106	0.00239	CcSEcCtD
Dipyridamole—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00105	0.00238	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00105	0.00238	CcSEcCtD
Dipyridamole—Convulsion—Dexamethasone—ankylosing spondylitis	0.00105	0.00238	CcSEcCtD
Dipyridamole—Convulsion—Betamethasone—ankylosing spondylitis	0.00105	0.00238	CcSEcCtD
Dipyridamole—Hypertension—Betamethasone—ankylosing spondylitis	0.00105	0.00237	CcSEcCtD
Dipyridamole—Hypertension—Dexamethasone—ankylosing spondylitis	0.00105	0.00237	CcSEcCtD
Dipyridamole—Myalgia—Betamethasone—ankylosing spondylitis	0.00103	0.00234	CcSEcCtD
Dipyridamole—Myalgia—Dexamethasone—ankylosing spondylitis	0.00103	0.00234	CcSEcCtD
Dipyridamole—Anxiety—Dexamethasone—ankylosing spondylitis	0.00103	0.00233	CcSEcCtD
Dipyridamole—Anxiety—Betamethasone—ankylosing spondylitis	0.00103	0.00233	CcSEcCtD
Dipyridamole—Discomfort—Dexamethasone—ankylosing spondylitis	0.00102	0.00231	CcSEcCtD
Dipyridamole—Discomfort—Betamethasone—ankylosing spondylitis	0.00102	0.00231	CcSEcCtD
Dipyridamole—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00102	0.0023	CcSEcCtD
Dipyridamole—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00102	0.0023	CcSEcCtD
Dipyridamole—Pain—Prednisolone—ankylosing spondylitis	0.00101	0.00229	CcSEcCtD
Dipyridamole—Hepatitis—Methotrexate—ankylosing spondylitis	0.00101	0.00229	CcSEcCtD
Dipyridamole—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00101	0.00229	CcSEcCtD
Dipyridamole—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00101	0.00228	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000993	0.00225	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000991	0.00224	CcSEcCtD
Dipyridamole—Oedema—Dexamethasone—ankylosing spondylitis	0.000989	0.00224	CcSEcCtD
Dipyridamole—Oedema—Betamethasone—ankylosing spondylitis	0.000989	0.00224	CcSEcCtD
Dipyridamole—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000989	0.00224	CcSEcCtD
Dipyridamole—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000989	0.00224	CcSEcCtD
Dipyridamole—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000979	0.00222	CcSEcCtD
Dipyridamole—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000979	0.00222	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000977	0.00221	CcSEcCtD
Dipyridamole—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000977	0.00221	CcSEcCtD
Dipyridamole—Anaemia—Prednisone—ankylosing spondylitis	0.000976	0.00221	CcSEcCtD
Dipyridamole—PDE3B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000974	0.0149	CbGpPWpGaD
Dipyridamole—Shock—Betamethasone—ankylosing spondylitis	0.000973	0.0022	CcSEcCtD
Dipyridamole—Shock—Dexamethasone—ankylosing spondylitis	0.000973	0.0022	CcSEcCtD
Dipyridamole—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000972	0.0022	CcSEcCtD
Dipyridamole—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00097	0.0022	CcSEcCtD
Dipyridamole—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00097	0.0022	CcSEcCtD
Dipyridamole—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000969	0.00219	CcSEcCtD
Dipyridamole—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000969	0.00219	CcSEcCtD
Dipyridamole—Tachycardia—Betamethasone—ankylosing spondylitis	0.000966	0.00218	CcSEcCtD
Dipyridamole—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000966	0.00218	CcSEcCtD
Dipyridamole—Angioedema—Prednisone—ankylosing spondylitis	0.000965	0.00218	CcSEcCtD
Dipyridamole—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00096	0.00217	CcSEcCtD
Dipyridamole—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000958	0.00217	CcSEcCtD
Dipyridamole—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000956	0.00216	CcSEcCtD
Dipyridamole—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000956	0.00216	CcSEcCtD
Dipyridamole—Malaise—Prednisone—ankylosing spondylitis	0.000952	0.00215	CcSEcCtD
Dipyridamole—Vertigo—Prednisone—ankylosing spondylitis	0.000948	0.00215	CcSEcCtD
Dipyridamole—Syncope—Prednisone—ankylosing spondylitis	0.000947	0.00214	CcSEcCtD
Dipyridamole—Tinnitus—Methotrexate—ankylosing spondylitis	0.000945	0.00214	CcSEcCtD
Dipyridamole—Urticaria—Prednisolone—ankylosing spondylitis	0.000942	0.00213	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000941	0.00213	CcSEcCtD
Dipyridamole—Fatigue—Triamcinolone—ankylosing spondylitis	0.00094	0.00213	CcSEcCtD
Dipyridamole—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000938	0.00212	CcSEcCtD
Dipyridamole—Pain—Triamcinolone—ankylosing spondylitis	0.000932	0.00211	CcSEcCtD
Dipyridamole—PDE6B—Disease—ANTXR2—ankylosing spondylitis	0.000932	0.0142	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—ANTXR2—ankylosing spondylitis	0.000932	0.0142	CbGpPWpGaD
Dipyridamole—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000928	0.0021	CcSEcCtD
Dipyridamole—Hypotension—Betamethasone—ankylosing spondylitis	0.000924	0.00209	CcSEcCtD
Dipyridamole—Hypotension—Dexamethasone—ankylosing spondylitis	0.000924	0.00209	CcSEcCtD
Dipyridamole—Angiopathy—Methotrexate—ankylosing spondylitis	0.000919	0.00208	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000915	0.00207	CcSEcCtD
Dipyridamole—Convulsion—Prednisone—ankylosing spondylitis	0.000915	0.00207	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000913	0.00207	CcSEcCtD
Dipyridamole—PDE4A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000912	0.0139	CbGpPWpGaD
Dipyridamole—Hypertension—Prednisone—ankylosing spondylitis	0.000911	0.00206	CcSEcCtD
Dipyridamole—Chills—Methotrexate—ankylosing spondylitis	0.000909	0.00206	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000901	0.00204	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000901	0.00204	CcSEcCtD
Dipyridamole—Myalgia—Prednisone—ankylosing spondylitis	0.000899	0.00203	CcSEcCtD
Dipyridamole—Arthralgia—Prednisone—ankylosing spondylitis	0.000899	0.00203	CcSEcCtD
Dipyridamole—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000898	0.00203	CcSEcCtD
Dipyridamole—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000896	0.00203	CcSEcCtD
Dipyridamole—Anxiety—Prednisone—ankylosing spondylitis	0.000896	0.00203	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—ankylosing spondylitis	0.000896	0.00203	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000893	0.00202	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00089	0.00201	CcSEcCtD
Dipyridamole—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000888	0.00201	CcSEcCtD
Dipyridamole—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000888	0.00201	CcSEcCtD
Dipyridamole—Discomfort—Prednisone—ankylosing spondylitis	0.000888	0.00201	CcSEcCtD
Dipyridamole—PDE3A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000887	0.0136	CbGpPWpGaD
Dipyridamole—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000873	0.00198	CcSEcCtD
Dipyridamole—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000871	0.00197	CcSEcCtD
Dipyridamole—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000871	0.00197	CcSEcCtD
Dipyridamole—PDE1C—Immune System—KIR3DL1—ankylosing spondylitis	0.00087	0.0133	CbGpPWpGaD
Dipyridamole—Urticaria—Triamcinolone—ankylosing spondylitis	0.000866	0.00196	CcSEcCtD
Dipyridamole—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000864	0.00196	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000864	0.00195	CcSEcCtD
Dipyridamole—Oedema—Prednisone—ankylosing spondylitis	0.000862	0.00195	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000862	0.00195	CcSEcCtD
Dipyridamole—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00086	0.00195	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000854	0.00193	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000854	0.00193	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—ankylosing spondylitis	0.000853	0.00193	CcSEcCtD
Dipyridamole—Fatigue—Betamethasone—ankylosing spondylitis	0.000853	0.00193	CcSEcCtD
Dipyridamole—Fatigue—Dexamethasone—ankylosing spondylitis	0.000853	0.00193	CcSEcCtD
Dipyridamole—Shock—Prednisone—ankylosing spondylitis	0.000848	0.00192	CcSEcCtD
Dipyridamole—Pain—Dexamethasone—ankylosing spondylitis	0.000846	0.00191	CcSEcCtD
Dipyridamole—Pain—Betamethasone—ankylosing spondylitis	0.000846	0.00191	CcSEcCtD
Dipyridamole—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000845	0.00191	CcSEcCtD
Dipyridamole—Tachycardia—Prednisone—ankylosing spondylitis	0.000841	0.0019	CcSEcCtD
Dipyridamole—Skin disorder—Prednisone—ankylosing spondylitis	0.000837	0.00189	CcSEcCtD
Dipyridamole—PDE1A—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000834	0.0128	CbGpPWpGaD
Dipyridamole—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000833	0.00188	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000819	0.00185	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—ankylosing spondylitis	0.000815	0.00185	CcSEcCtD
Dipyridamole—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000815	0.00184	CcSEcCtD
Dipyridamole—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000815	0.00184	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000809	0.00183	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000809	0.00183	CcSEcCtD
Dipyridamole—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000803	0.00182	CcSEcCtD
Dipyridamole—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000801	0.00181	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—ankylosing spondylitis	0.000796	0.0018	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—ankylosing spondylitis	0.000793	0.00179	CcSEcCtD
Dipyridamole—Urticaria—Betamethasone—ankylosing spondylitis	0.000786	0.00178	CcSEcCtD
Dipyridamole—Urticaria—Dexamethasone—ankylosing spondylitis	0.000786	0.00178	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000785	0.00178	CcSEcCtD
Dipyridamole—PDE1C—Innate Immune System—CARD9—ankylosing spondylitis	0.000785	0.012	CbGpPWpGaD
Dipyridamole—Dizziness—Prednisolone—ankylosing spondylitis	0.000784	0.00177	CcSEcCtD
Dipyridamole—Asthenia—Triamcinolone—ankylosing spondylitis	0.000782	0.00177	CcSEcCtD
Dipyridamole—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000782	0.00177	CcSEcCtD
Dipyridamole—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000782	0.00177	CcSEcCtD
Dipyridamole—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000781	0.00177	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisone—ankylosing spondylitis	0.000774	0.00175	CcSEcCtD
Dipyridamole—Pruritus—Triamcinolone—ankylosing spondylitis	0.000771	0.00175	CcSEcCtD
Dipyridamole—Cough—Methotrexate—ankylosing spondylitis	0.00077	0.00174	CcSEcCtD
Dipyridamole—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00077	0.00174	CcSEcCtD
Dipyridamole—ABCC5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000765	0.0117	CbGpPWpGaD
Dipyridamole—Convulsion—Methotrexate—ankylosing spondylitis	0.000764	0.00173	CcSEcCtD
Dipyridamole—PDE1B—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.000763	0.0117	CbGpPWpGaD
Dipyridamole—Dyspepsia—Prednisone—ankylosing spondylitis	0.000758	0.00172	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—ankylosing spondylitis	0.000751	0.0017	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—ankylosing spondylitis	0.000751	0.0017	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—ankylosing spondylitis	0.000751	0.0017	CcSEcCtD
Dipyridamole—PDE1C—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00075	0.0115	CbGpPWpGaD
Dipyridamole—Rash—Prednisolone—ankylosing spondylitis	0.000748	0.00169	CcSEcCtD
Dipyridamole—Dermatitis—Prednisolone—ankylosing spondylitis	0.000747	0.00169	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000746	0.00169	CcSEcCtD
Dipyridamole—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000744	0.00168	CcSEcCtD
Dipyridamole—Fatigue—Prednisone—ankylosing spondylitis	0.000743	0.00168	CcSEcCtD
Dipyridamole—Headache—Prednisolone—ankylosing spondylitis	0.000743	0.00168	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—ankylosing spondylitis	0.000742	0.00168	CcSEcCtD
Dipyridamole—Dizziness—Triamcinolone—ankylosing spondylitis	0.000721	0.00163	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00072	0.00163	CcSEcCtD
Dipyridamole—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000719	0.00163	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00071	0.00161	CcSEcCtD
Dipyridamole—Asthenia—Betamethasone—ankylosing spondylitis	0.00071	0.00161	CcSEcCtD
Dipyridamole—Asthenia—Dexamethasone—ankylosing spondylitis	0.00071	0.00161	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000706	0.0016	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000705	0.0016	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000704	0.00159	CcSEcCtD
Dipyridamole—Nausea—Prednisolone—ankylosing spondylitis	0.000704	0.00159	CcSEcCtD
Dipyridamole—Pruritus—Dexamethasone—ankylosing spondylitis	0.0007	0.00158	CcSEcCtD
Dipyridamole—Pruritus—Betamethasone—ankylosing spondylitis	0.0007	0.00158	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—ankylosing spondylitis	0.000699	0.00158	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000696	0.00157	CcSEcCtD
Dipyridamole—Vomiting—Triamcinolone—ankylosing spondylitis	0.000693	0.00157	CcSEcCtD
Dipyridamole—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000692	0.00157	CcSEcCtD
Dipyridamole—Rash—Triamcinolone—ankylosing spondylitis	0.000687	0.00156	CcSEcCtD
Dipyridamole—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000687	0.00155	CcSEcCtD
Dipyridamole—Rash—Methylprednisolone—ankylosing spondylitis	0.000686	0.00155	CcSEcCtD
Dipyridamole—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000685	0.00155	CcSEcCtD
Dipyridamole—Urticaria—Prednisone—ankylosing spondylitis	0.000684	0.00155	CcSEcCtD
Dipyridamole—Headache—Triamcinolone—ankylosing spondylitis	0.000683	0.00155	CcSEcCtD
Dipyridamole—Headache—Methylprednisolone—ankylosing spondylitis	0.000682	0.00154	CcSEcCtD
Dipyridamole—Abdominal pain—Prednisone—ankylosing spondylitis	0.000681	0.00154	CcSEcCtD
Dipyridamole—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000677	0.00153	CcSEcCtD
Dipyridamole—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000677	0.00153	CcSEcCtD
Dipyridamole—PDE1A—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000676	0.0103	CbGpPWpGaD
Dipyridamole—ABCC5—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000675	0.0103	CbGpPWpGaD
Dipyridamole—Hypotension—Methotrexate—ankylosing spondylitis	0.000673	0.00152	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000656	0.00148	CcSEcCtD
Dipyridamole—Dizziness—Betamethasone—ankylosing spondylitis	0.000654	0.00148	CcSEcCtD
Dipyridamole—Dizziness—Dexamethasone—ankylosing spondylitis	0.000654	0.00148	CcSEcCtD
Dipyridamole—Nausea—Triamcinolone—ankylosing spondylitis	0.000648	0.00147	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000647	0.00146	CcSEcCtD
Dipyridamole—Nausea—Methylprednisolone—ankylosing spondylitis	0.000646	0.00146	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000642	0.00145	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—ankylosing spondylitis	0.00064	0.00145	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000635	0.00144	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000634	0.00143	CcSEcCtD
Dipyridamole—Vomiting—Betamethasone—ankylosing spondylitis	0.000629	0.00142	CcSEcCtD
Dipyridamole—Vomiting—Dexamethasone—ankylosing spondylitis	0.000629	0.00142	CcSEcCtD
Dipyridamole—Rash—Betamethasone—ankylosing spondylitis	0.000624	0.00141	CcSEcCtD
Dipyridamole—Rash—Dexamethasone—ankylosing spondylitis	0.000624	0.00141	CcSEcCtD
Dipyridamole—Dermatitis—Betamethasone—ankylosing spondylitis	0.000623	0.00141	CcSEcCtD
Dipyridamole—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000623	0.00141	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000622	0.00141	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—ankylosing spondylitis	0.000621	0.0014	CcSEcCtD
Dipyridamole—Headache—Dexamethasone—ankylosing spondylitis	0.00062	0.0014	CcSEcCtD
Dipyridamole—Headache—Betamethasone—ankylosing spondylitis	0.00062	0.0014	CcSEcCtD
Dipyridamole—Asthenia—Prednisone—ankylosing spondylitis	0.000618	0.0014	CcSEcCtD
Dipyridamole—PDE1B—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000618	0.00945	CbGpPWpGaD
Dipyridamole—Pain—Methotrexate—ankylosing spondylitis	0.000616	0.00139	CcSEcCtD
Dipyridamole—Pruritus—Prednisone—ankylosing spondylitis	0.00061	0.00138	CcSEcCtD
Dipyridamole—PDE1C—Disease—ANTXR2—ankylosing spondylitis	0.000609	0.00931	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—ANTXR2—ankylosing spondylitis	0.000601	0.00918	CbGpPWpGaD
Dipyridamole—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000593	0.00134	CcSEcCtD
Dipyridamole—Diarrhoea—Prednisone—ankylosing spondylitis	0.000589	0.00133	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000589	0.00133	CcSEcCtD
Dipyridamole—Nausea—Betamethasone—ankylosing spondylitis	0.000588	0.00133	CcSEcCtD
Dipyridamole—Nausea—Dexamethasone—ankylosing spondylitis	0.000588	0.00133	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—ankylosing spondylitis	0.000572	0.00129	CcSEcCtD
Dipyridamole—Dizziness—Prednisone—ankylosing spondylitis	0.00057	0.00129	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000569	0.00129	CcSEcCtD
Dipyridamole—PDE6A—Disease—B3GNT2—ankylosing spondylitis	0.000549	0.0084	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—B3GNT2—ankylosing spondylitis	0.000549	0.0084	CbGpPWpGaD
Dipyridamole—Vomiting—Prednisone—ankylosing spondylitis	0.000548	0.00124	CcSEcCtD
Dipyridamole—Rash—Prednisone—ankylosing spondylitis	0.000543	0.00123	CcSEcCtD
Dipyridamole—Dermatitis—Prednisone—ankylosing spondylitis	0.000543	0.00123	CcSEcCtD
Dipyridamole—Headache—Prednisone—ankylosing spondylitis	0.00054	0.00122	CcSEcCtD
Dipyridamole—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00053	0.0012	CcSEcCtD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00053	0.00811	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL1R2—ankylosing spondylitis	0.000527	0.00806	CbGpPWpGaD
Dipyridamole—Asthenia—Methotrexate—ankylosing spondylitis	0.000517	0.00117	CcSEcCtD
Dipyridamole—Nausea—Prednisone—ankylosing spondylitis	0.000512	0.00116	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—ankylosing spondylitis	0.000509	0.00115	CcSEcCtD
Dipyridamole—PDE1C—Immune System—ERAP1—ankylosing spondylitis	0.0005	0.00764	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—HLA-C—ankylosing spondylitis	0.000493	0.00753	CbGpPWpGaD
Dipyridamole—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000493	0.00111	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—ankylosing spondylitis	0.000476	0.00108	CcSEcCtD
Dipyridamole—PDE1A—Immune System—KIR3DL1—ankylosing spondylitis	0.000463	0.00709	CbGpPWpGaD
Dipyridamole—Vomiting—Methotrexate—ankylosing spondylitis	0.000458	0.00104	CcSEcCtD
Dipyridamole—PDE1C—Immune System—CARD9—ankylosing spondylitis	0.000457	0.00699	CbGpPWpGaD
Dipyridamole—Rash—Methotrexate—ankylosing spondylitis	0.000454	0.00103	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—ankylosing spondylitis	0.000454	0.00103	CcSEcCtD
Dipyridamole—Headache—Methotrexate—ankylosing spondylitis	0.000451	0.00102	CcSEcCtD
Dipyridamole—Nausea—Methotrexate—ankylosing spondylitis	0.000428	0.000968	CcSEcCtD
Dipyridamole—PDE1B—Immune System—KIR3DL1—ankylosing spondylitis	0.000424	0.00648	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000418	0.00639	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000418	0.00639	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—CARD9—ankylosing spondylitis	0.000418	0.00639	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000408	0.00623	CbGpPWpGaD
Dipyridamole—PDE1A—DAP12 interactions—HLA-B—ankylosing spondylitis	0.0004	0.00611	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CARD9—ankylosing spondylitis	0.000382	0.00584	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00038	0.0058	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00038	0.0058	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000373	0.0057	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00037	0.00566	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000365	0.00559	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—B3GNT2—ankylosing spondylitis	0.000359	0.00548	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000354	0.00541	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—B3GNT2—ankylosing spondylitis	0.000354	0.00541	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000346	0.0053	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000346	0.0053	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000338	0.00517	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—ANTXR2—ankylosing spondylitis	0.000324	0.00496	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—ANTXR2—ankylosing spondylitis	0.000324	0.00496	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000324	0.00495	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000315	0.00481	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000315	0.00481	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000309	0.00472	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000301	0.0046	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—ANTXR2—ankylosing spondylitis	0.000297	0.00453	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000292	0.00446	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—HLA-B—ankylosing spondylitis	0.000291	0.00445	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HLA-C—ankylosing spondylitis	0.000287	0.00439	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1R2—ankylosing spondylitis	0.000281	0.00429	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00028	0.00429	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00027	0.00413	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00027	0.00413	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—ERAP1—ankylosing spondylitis	0.000266	0.00407	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000264	0.00403	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000264	0.00403	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000263	0.00403	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—HLA-C—ankylosing spondylitis	0.000263	0.00401	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—CRP—ankylosing spondylitis	0.000258	0.00394	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1R2—ankylosing spondylitis	0.000257	0.00393	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL1RN—ankylosing spondylitis	0.000249	0.00381	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—TLR4—ankylosing spondylitis	0.000247	0.00377	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CARD9—ankylosing spondylitis	0.000243	0.00372	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ERAP1—ankylosing spondylitis	0.000243	0.00372	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000241	0.00368	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—HLA-C—ankylosing spondylitis	0.00024	0.00367	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000224	0.00343	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000224	0.00343	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000224	0.00342	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000224	0.00342	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CARD9—ankylosing spondylitis	0.000223	0.0034	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—HLA-A—ankylosing spondylitis	0.000222	0.0034	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—HLA-A—ankylosing spondylitis	0.000222	0.0034	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000221	0.00338	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—B3GNT2—ankylosing spondylitis	0.00022	0.00337	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.00022	0.00336	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.00022	0.00336	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD79A—ankylosing spondylitis	0.000219	0.00335	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000219	0.00334	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00021	0.00321	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000209	0.0032	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000208	0.00318	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—PTGER4—ankylosing spondylitis	0.0002	0.00306	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.0002	0.00305	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.0002	0.00305	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000194	0.00297	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—B3GNT2—ankylosing spondylitis	0.000191	0.00292	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—B3GNT2—ankylosing spondylitis	0.000191	0.00292	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—MMP3—ankylosing spondylitis	0.000188	0.00287	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—MMP3—ankylosing spondylitis	0.000188	0.00287	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000187	0.00286	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000186	0.00284	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000186	0.00284	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000182	0.00278	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000181	0.00277	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL1A—ankylosing spondylitis	0.000179	0.00274	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD40LG—ankylosing spondylitis	0.000178	0.00273	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—B3GNT2—ankylosing spondylitis	0.000175	0.00267	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000172	0.00263	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000171	0.00262	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00017	0.0026	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00017	0.0026	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HLA-B—ankylosing spondylitis	0.00017	0.00259	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000166	0.00253	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000165	0.00253	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—B3GNT2—ankylosing spondylitis	0.00016	0.00245	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MMP3—ankylosing spondylitis	0.00016	0.00244	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MMP3—ankylosing spondylitis	0.00016	0.00244	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HLA-A—ankylosing spondylitis	0.000157	0.0024	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000157	0.00239	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MMP3—ankylosing spondylitis	0.000156	0.00238	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000155	0.00238	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—HLA-B—ankylosing spondylitis	0.000155	0.00237	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-C—ankylosing spondylitis	0.000153	0.00234	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CRP—ankylosing spondylitis	0.00015	0.00229	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—HLA-A—ankylosing spondylitis	0.000145	0.00222	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—TLR4—ankylosing spondylitis	0.000144	0.0022	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—HLA-A—ankylosing spondylitis	0.000143	0.00219	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MMP3—ankylosing spondylitis	0.000142	0.00218	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000142	0.00217	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—HLA-B—ankylosing spondylitis	0.000142	0.00217	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-C—ankylosing spondylitis	0.00014	0.00214	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—CRP—ankylosing spondylitis	0.000137	0.0021	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1RN—ankylosing spondylitis	0.000133	0.00203	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MMP3—ankylosing spondylitis	0.000132	0.00202	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MMP3—ankylosing spondylitis	0.000132	0.00202	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—TLR4—ankylosing spondylitis	0.000132	0.00201	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000129	0.00198	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CRP—ankylosing spondylitis	0.000125	0.00192	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MMP3—ankylosing spondylitis	0.000123	0.00188	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1RN—ankylosing spondylitis	0.000121	0.00186	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MMP3—ankylosing spondylitis	0.000121	0.00185	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000121	0.00185	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—TLR4—ankylosing spondylitis	0.00012	0.00184	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MMP3—ankylosing spondylitis	0.000118	0.0018	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000118	0.0018	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD79A—ankylosing spondylitis	0.000117	0.00178	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000111	0.00169	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000107	0.00164	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD79A—ankylosing spondylitis	0.000107	0.00163	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000101	0.00155	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.0001	0.00153	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PTGER4—ankylosing spondylitis	9.76e-05	0.00149	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1A—ankylosing spondylitis	9.56e-05	0.00146	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD40LG—ankylosing spondylitis	9.51e-05	0.00145	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PTGER4—ankylosing spondylitis	9.18e-05	0.0014	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-B—ankylosing spondylitis	9.04e-05	0.00138	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1A—ankylosing spondylitis	8.74e-05	0.00134	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD40LG—ankylosing spondylitis	8.69e-05	0.00133	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTGER4—ankylosing spondylitis	8.4e-05	0.00128	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-A—ankylosing spondylitis	8.38e-05	0.00128	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	8.38e-05	0.00128	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-B—ankylosing spondylitis	8.27e-05	0.00126	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CRP—ankylosing spondylitis	7.99e-05	0.00122	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HLA-A—ankylosing spondylitis	7.73e-05	0.00118	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HLA-A—ankylosing spondylitis	7.73e-05	0.00118	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—TLR4—ankylosing spondylitis	7.66e-05	0.00117	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-A—ankylosing spondylitis	7.66e-05	0.00117	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP3—ankylosing spondylitis	7.63e-05	0.00117	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CRP—ankylosing spondylitis	7.31e-05	0.00112	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP3—ankylosing spondylitis	7.15e-05	0.00109	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HLA-A—ankylosing spondylitis	7.07e-05	0.00108	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—TLR4—ankylosing spondylitis	7.01e-05	0.00107	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP3—ankylosing spondylitis	6.95e-05	0.00106	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP3—ankylosing spondylitis	6.54e-05	0.000999	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP3—ankylosing spondylitis	5.98e-05	0.000914	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	4.4e-05	0.000672	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	4.13e-05	0.000632	CbGpPWpGaD
